Pathogenesis, Management, and Consequences of Primary Graft Dysfunction

被引:21
作者
Carter, Yvette M. [1 ]
Gelman, Andrew E. [1 ]
Kreisel, Daniel [1 ]
机构
[1] Washington Univ, Dept Surg, Div Cardiothorac Surg, Campus Box 8234,660 South Euclid Ave, St Louis, MO 63110 USA
关键词
lung transplantation; primary graft dysfunction;
D O I
10.1053/j.semtcvs.2008.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary graft dysfunction continues to be a major contributing factor to morbidity and mortality after lung transplantation. This condition is presumed to be the result of ischemia-reperfusion injury, which is associated with the release of endogenous substances that can activate the innate immune system. Primary graft dysfunction has been shown to be an independent risk factor for the development of bronchiolitis obliterans syndrome indicating that it can shape alloimmune responses. In this review, we focus on the classification, pathogenesis, possible prevention strategies, management and consequences of primary graft dysfunction. © 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 75 条
[1]   EFFECT OF CARDIOPULMONARY BYPASS ON EARLY GRAFT DYSFUNCTION IN CLINICAL LUNG TRANSPLANTATION [J].
AEBA, R ;
GRIFFITH, BP ;
KORMOS, RL ;
ARMITAGE, JM ;
GASIOR, TA ;
FUHRMAN, CR ;
YOUSEM, SA ;
HARDESTY, RL .
ANNALS OF THORACIC SURGERY, 1994, 57 (03) :715-722
[2]   A prospective trial of inhaled nitric oxide in clinical lung transplantation [J].
Ardehali, A ;
Laks, H ;
Levine, M ;
Shpiner, R ;
Ross, D ;
Watson, LD ;
Shvartz, O ;
Sangwan, S ;
Waters, PF .
TRANSPLANTATION, 2001, 72 (01) :112-115
[3]   Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation [J].
Avlonitis, V. S. ;
Wigfield, C. H. ;
Golledge, H. D. R. ;
Kirby, J. A. ;
Dark, J. H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (01) :83-90
[4]   Pulmonary transplantation: The role of brain death in donor lung injury. [J].
Avlonitis, VS ;
Fisher, AJ ;
Kirby, JA ;
Dark, JH .
TRANSPLANTATION, 2003, 75 (12) :1928-1933
[5]  
Batten P, 1996, IMMUNOLOGY, V87, P127
[6]   Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation [J].
Bittner, HB ;
Richter, M ;
Kuntze, T ;
Rahmel, A ;
Dahlberg, P ;
Hertz, M ;
Mohr, FW .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2006, 29 (02) :210-215
[7]   Respiratory failure after lung transplantation [J].
Chatila, WM ;
Furukawa, S ;
Gaughan, JP ;
Criner, GJ .
CHEST, 2003, 123 (01) :165-173
[8]   Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation [J].
Christie, JD ;
Carby, M ;
Bag, R ;
Corris, P ;
Hertz, M ;
Weill, D .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10) :1454-1459
[9]   The effect of primary graft dysfunction on survival after lung transplantation [J].
Christie, JD ;
Kotloff, RM ;
Ahya, VN ;
Tino, G ;
Pochettino, A ;
Gaughan, C ;
DeMissie, E ;
Kimmel, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (11) :1312-1316
[10]   Clinical risk factors for primary graft failure following lung transplantation [J].
Christie, JD ;
Kotloff, RM ;
Pochettino, A ;
Arcasoy, SM ;
Rosengard, BR ;
Landis, JR ;
Kimmel, SE .
CHEST, 2003, 124 (04) :1232-1241